Denver, CO, September 06, 2014 --(PR.com
)-- The Colorado BioScience Association (CBSA) is launching new “BioTalks” at BioWest this year. These are eight fast-paced presentations about the big and bold ideas in the Bioscience Industry. The announcement is made by CBSA President & CEO April Giles, who says, “This year we’ve added energy and excitement to our lineup with the new BioTalk segments during regular programming and the new C-Level Unplugged interviews on center stage in the Expo Hall. Further, we’re very excited about the number of high caliber keynote speakers at BioWest 2014, including FDA Commissioner Dr. Margaret Hamburg, Russell Slifer the newly appointed Director of the Rocky Mountain Region’s Satellite U.S. Patent and Trade Mark Office, CEO presentations, and the wide variety of products and services on display in the Expo Hall.”
The 2014 BioWest Conference & Expo, is September 10, at the Marriott City Center, 1701 California Street, Denver.
BioTalks are scheduled at both 10:45 a.m. and 3:00 p.m.
Trends in Healthcare: Investments & Exits Jonathan Norris, Managing Director, Silicon Valley Bank
Ethics in Clinical Trials David Gary, RN, MS, Director, Human Research Protection Program, Catholic Health Initiatives/CHI Institute for Research & Innovation (CIRI)
Harnessing the Power of Real World Data to Identify What Works for Whom in Healthcare Iya Khalil, Ph.D., Executive Vice President and Co-Founder, GNS Healthcare
Cultivating the Innovation Economy Robert Atkinson, President, Information Technology and Innovation Foundation
The Truth behind Superbugs Rhea May, Ph.D., Research Scientist, Sharklet Technologies
Leveraging Outsourcing to Bridge the Valley of Death: Advantages & Pitfalls Larry Blankenship, Executive Director, Evergreen Research
Industry Cross Collaboration Mark Sirangelo, Chief Innovation Officer, State of Colorado; Corporate VP of Space Systems, Sierra Nevada Corp
Beer Fermentation Science: Yeast Strains & Sensory Perception Lindsay Guerdrum, Sensory Specialist, New Belgium Brewing
Also new this year: C-Level Unplugged
In addition to BioTalk presentations, BioWest 2014 is also debuting two sessions of “C-Level Unplugged: Conversations with top level leadership.” The morning session, 9:20 – 9:35, will feature a fast-paced interview on the Exhibit Hall stage with Larry Gold, Chairman of the Board, SomaLogic. The afternoon session, 1:15 – 1:30 pm, features Shahriar (Shar) Matin, Chief Operating Officer of Spectranetics. Jim Wilson, partner, EY, will conduct the interview for both sessions during the conference.
About BioWest 2014 | September 10, 2014 | #BioWest2014
The BioWest Conference is a one day event attended by more than 300 industry leaders, government representatives, executives, researchers, investors and entrepreneurs.
The conference features speakers Margaret A. Hamburg, M.D., Commissioner of the U.S. Food and Drug Administration (her ‘Update on the FDA’ keynote will occur at 4:45 pm) sponsored by Dohmen and keynote panelists; Jandel Allen-Davis, M.D., Vice President, Government and External Relations, Kaiser Permanente Colorado; James Hill, Ph.D. is Professor of Pediatrics and Medicine at the University of Colorado School of Medicine; Len Tacconi, President, HMR Weight Management Services Corp., a subsidiary of Merck & Co. Inc.; sponsored by the Fitzsimons Redevelopment Authority and Russell Slifer, Director, United States Patent & Trademark, Rocky Mountain Regional Office sponsored by Sheridan Ross PC. The full schedule of the day’s events is found at: http://www.cobioscience.com/biowest/schedule.
Registration is now open at http://www.CoBioScience.com/BioWest. Rates for members start at $325 and $375 for non-members and passes for the expo hall & reception only are $125 for members and $150 for non-members. Group rates are available for companies and organizations. BioWest 2014 also includes an Exhibit Hall with over 40 exhibitors showcase new technologies, products and services to attendees. Conference Sponsors include: AdvaMed, Amgen, BIO, BioFrontiers Institute, DePuy Synthes, DaVita Clinical Research, Dorsey & Whitney LLP, Dohmen Life Science Services, EY, Evergreen Research, Fitzsimons Redevelopment Authority, Fisher Scientific, Metro Denver EDC, The Mead Consulting Group, Quintiles, SomaLogic, Sheridan Ross PC, Square 1 Bank, Silicon Valley Bank and TerumoBCT.
About Colorado BioScience Association
CBSA is a not-for-profit organization providing services and support for Colorado's bioscience industry. With more than 350 members, CBSA actively works to promote the growth of the industry by advocating for a better business environment, growing the state's biotech workforce, fighting for policies that support a strong bioscience industry in the state, and speaking with a single voice on behalf of the industry. For more information, visit http://www.cobioscience.com.
CBSA also is found on these social media sites:
Twitter: http://www.twitter.com/COBioscience #BioWest2014
LinkedIn Group: http://www.linkedin.com/groups?about=&gid=98468&trk=anet_ug_grppro
Facebook Fan Page: http://www.facebook.com/ColoradoBioScienceAssociation
Mae Desaire, Director of Marketing, Colorado BioScience Association - http://www.cobioscience.com – 720-382-5918, firstname.lastname@example.org
Maggie Chamberlin Holben, APR, Absolutely Public Relations - http://www.absolutelypr.com - 303-984-9801, email@example.com